These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28176473)

  • 1. Durable remission of C3 glomerulonephritis with mycophenolate mofetil.
    Lioufas N; Finlay M; Barbour T
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():36-39. PubMed ID: 28176473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.
    Caravaca-Fontán F; Díaz-Encarnación MM; Lucientes L; Cavero T; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez A; Pérez de José A; Rabasco C; Rodado R; Fernández L; Pérez Gómez V; Ávila AI; Bravo L; Lumbreras J; Allende N; Sanchez de la Nieta MD; Rodríguez E; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; Cano-Megías M; González F; Shabaka A; López-Rubio ME; Fenollosa MÁ; Martín-Penagos L; Da Silva I; Alonso Titos J; Rodríguez de Córdoba S; Goicoechea de Jorge E; Praga M;
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1287-1298. PubMed ID: 32816888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.
    Avasare RS; Canetta PA; Bomback AS; Marasa M; Caliskan Y; Ozluk Y; Li Y; Gharavi AG; Appel GB
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):406-413. PubMed ID: 29326307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
    Rabasco C; Cavero T; Román E; Rojas-Rivera J; Olea T; Espinosa M; Cabello V; Fernández-Juarez G; González F; Ávila A; Baltar JM; Díaz M; Alegre R; Elías S; Antón M; Frutos MA; Pobes A; Blasco M; Martín F; Bernis C; Macías M; Barroso S; de Lorenzo A; Ariceta G; López-Mendoza M; Rivas B; López-Revuelta K; Campistol JM; Mendizábal S; de Córdoba SR; Praga M;
    Kidney Int; 2015 Nov; 88(5):1153-60. PubMed ID: 26221755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options.
    Bartoli G; Dello Strologo A; Grandaliano G; Pesce F
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
    Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
    BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
    Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
    Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience.
    Yeter HH; Sütiçen E; Korucu B; Helvaci Ö; Özbaş B; Gönül İ; Derici Ü; Arinsoy T; Güz G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):15-23. PubMed ID: 31605593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.
    Serra N; Facundo C; Canal C; Arce Y; Ayasreh N; Vila A; Bardají B; Silva I; López V; Benito S; Ballarín J; Guirado L
    Nefrologia (Engl Ed); 2019; 39(2):198-201. PubMed ID: 29914760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
    Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
    BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.
    Chauvet S; Roumenina LT; Aucouturier P; Marinozzi MC; Dragon-Durey MA; Karras A; Delmas Y; Le Quintrec M; Guerrot D; Jourde-Chiche N; Ribes D; Ronco P; Bridoux F; Fremeaux-Bacchi V
    Front Immunol; 2018; 9():2260. PubMed ID: 30333829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent C3 glomerulopathy after kidney transplantation.
    Obata S; Vaz de Castro PAS; Riella LV; Cravedi P
    Transplant Rev (Orlando); 2024 Apr; 38(2):100839. PubMed ID: 38412598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of C3 glomerulopathy with complement blockers.
    Vivarelli M; Emma F
    Semin Thromb Hemost; 2014 Jun; 40(4):472-7. PubMed ID: 24799307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
    Häffner K; Michelfelder S; Pohl M
    Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 78-Year-Old Man with Chronic Kidney Disease and Monoclonal Gammopathy Who Developed Post-Transplant C3 Glomerulopathy - Recurrence or De Novo? A Case Report and Literature Review.
    Ruiz-Fuentes MC; Caba-Molina M; Polo-Moyano A; Palomares-Bayo M; Galindo-Sacristan P; De Gracia-Guindo C
    Am J Case Rep; 2023 Jun; 24():e939726. PubMed ID: 37329130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?
    Günay N; Dursun İ; Gökçe İ; Akbalık Kara M; Tekcan D; Çiçek N; Torun Bayram M; Koyun M; Dinçel N; Dursun H; Saygılı S; Yürük Yıldırım ZN; Yüksel S; Dönmez O; Yel S; Demircioğlu Kılıç B; Aydoğ Ö; Atmış B; Çaltık Yılmaz A; Bakkaloğlu SA; Aytaç MB; Taşdemir M; Kasap Demir B; Soylu A; Çomak E; Kantar Özşahin A; Kaçar A; Canpolat N; Yılmaz A; Girişgen İ; Akkoyunlu KB; Alpay H; Poyrazoğlu HM
    Pediatr Nephrol; 2024 May; 39(5):1435-1446. PubMed ID: 38041748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: a diagnostic and therapeutic challenge.
    Beirão B; Freitas M; Silva N; Ferraz P; Prata C; Morgado T
    J Bras Nefrol; 2024; 46(4):e20240092. PubMed ID: 39284028
    [No Abstract]   [Full Text] [Related]  

  • 19. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on C3 Glomerulopathy: A Complement-Mediated Disease.
    Caravaca-Fontán F; Lucientes L; Cavero T; Praga M
    Nephron; 2020; 144(6):272-280. PubMed ID: 32369815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.